GlucoTrack, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GCTK research report →
Price Chart
About the company
GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBGM, a long-term implantable continuous blood glucose monitoring system for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.
- CEO
- Erik Emerson
- IPO
- 2013
- Employees
- 15
- HQ
- Rutherford, NJ, US
Get TickerSpark's AI analysis on GCTK
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $179.58K
- P/E
- -0.00
- PEG
- -0.00
- P/S
- 0.00
- P/B
- -0.03
- EV/EBITDA
- 0.06
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -2135.52%
- ROIC
- 460.04%
Latest fiscal year · YoY change
- Revenue
- $0+0.0%
- Gross Profit
- $0+0.0%
- Op Income
- $-16,090,000
- Net Income
- $-19,388,000+14.2%
- EPS
- $-646.80+64.5%
- OCF Growth
- -22.0%
- FCF Growth
- -21.8%
- 52W High
- $207.00
- 52W Low
- $0.34
- 50D MA
- $3.84
- 200D MA
- $22.16
- Beta
- 0.72
- RSI (14)
- 28
- Avg Volume
- 1.88M
No earnings-call transcripts are available for GCTK yet.
- Free Float
- 80.3%
- Shares Outstanding
- 399.07K
- Float Shares
- 320.58K
of shares held by institutions
18 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Citadel Advisors LLC | 79.53K | ▲ 79.53K |
| Hrt Financial LP | 58.50K | ▼ 146.94K |
| Ikarian Capital, LLC | 45.83K | 0 |
| Bank Of America Corp | 22.15K | ▲ 22.15K |
| Virtu Financial LLC | 18.73K | ▲ 18.73K |
| Susquehanna International Group, Llp | 10.55K | ▲ 10.55K |
| Ubs Group AG | 7.89K | ▼ 5.45K |
| Tower Research Capital LLC (Trc) | 3.01K | ▼ 429 |
| Citigroup Inc | 101 | ▼ 12.77K |
| Osaic Holdings, Inc. | 2 | ▲ 2 |
| Morgan Stanley | 1 | ▲ 1 |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 22, 25 | CARR BRENDEL VICTORIA | other | 0 |
| Oct 3, 25 | Balo Andrew K | other | 1,285 |
| Oct 3, 25 | Balo Andrew K | other | 4,055 |
| Jul 11, 25 | Balo Andrew K | other | 3,332 |
| Mar 25, 25 | Balo Andrew K | other | 75 |
| Oct 3, 25 | Malave Luis | other | 463 |
| Oct 3, 25 | Malave Luis | other | 4,055 |
| Jul 11, 25 | Malave Luis | other | 1,200 |
| Mar 25, 25 | Malave Luis | other | 35 |
| Oct 3, 25 | Carter Erin Catherine | other | 4,055 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our GCTK coverage
Recent articles, reports, and earnings notes.
No research on GCTK yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GCTK report →Glucotrack, Inc. Announces Reverse Stock Split
businesswire.com · Oct 22
Glucotrack, Inc. Announces Pricing of $3 Million Public Offering
gurufocus.com · Sep 24
Glucotrack, Inc. Announces Pricing of $3 Million Public Offering
businesswire.com · Sep 24
Why GlucoTrack Shares Are Trading Higher By Around 118%; Here Are 20 Stocks Moving Premarket
benzinga.com · Sep 24
Lōkahi Therapeutics™ and Glucotrack CEO Erik Emerson Provides Strategic Update on LT-100, ai² Platform Growth and Clinical Development Priorities
businesswire.com · Sep 23
Lōkahi Therapeutics™ Continues ai² Pipeline™ Division Collaboration with The University of Alabama to Advance Asset Evaluation and Biopharma Talent
gurufocus.com · Sep 18
Glucotrack Announces $11.5 Million Financing
gurufocus.com · Sep 11
Glucotrack Announces $11.5 Million Financing
businesswire.com · Sep 11
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.